Toggle navigation
Home
Search
Services
Blog
Contact
About
Technetium Labeled Antibodies for Diagnosis
Reno, John M.
Neorx Corporation, Seattle, WA, United States
Search 3 grants from John Reno
Search grants from Neorx Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
NETS in thrombosis and inflammatory responses
Behavioral Screen for Cone Mutations
Pediatric Center for Complementary/Alternative Medicine
Vertical Transmission of HIV
Plasma Lipoproteins in Coronary Artery Disease
Recently added grants:
Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV
Balancing protective immunity and chronic sequelae by resident CD8 T cells
Elucidating Germinal Center-Mediated Antibody Evolution
Mechanisms of Intrinsic Host Responses to Hantavirus Infection
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067940-001
Application #
3614580
Study Section
Project Start
1986-09-24
Project End
Budget Start
1986-11-01
Budget End
1987-03-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Neorx Corporation
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98119
Related projects
NIH 1987
N43 CM
Technetium Labeled Antibodies for Diagnosis
Reno, John M. / Neorx Corporation
NIH 1986
N43 CM
Technetium Labeled Antibodies for Diagnosis
Reno, John M. / Neorx Corporation
Comments
Be the first to comment on this grant